Stroke induced by middle cerebral artery occlusion in adult rodents induces the formation of new neurons in the damaged striatum, a region that normally does not show neurogenesis. Here we describe recent findings on the regulation of neurogenesis after stroke, in particular regarding the duration of the neurogenic response and the influence of age, as well as the molecular mechanisms influencing migration and survival of the new neurons. We also discuss some crucial issues that need to be addressed in the further exploration of this potential self-repair mechanism after damage to the adult brain.
Introduction
Ischemic stroke induced by middle cerebral artery occlusion (MCAO), causing infarction in the striatum and cerebral cortex, gives rise to increased cell proliferation in the adult rat subventricular zone (SVZ) (Jin and others 2001; Zhang and others 2001; Zhang R, Zhang Z, Zhang C, and others 2004) . The newly formed neuroblasts migrate from the SVZ into the damaged striatum (Arvidsson and others 2002; Parent and others 2002; Jin and others 2003; Zhang R, Zhang Z, Wang, and others 2004) , a region in which neurogenesis does not occur in the intact brain. After differentiation, a substantial proportion of the new neurons express markers characteristic of the mature neurons that died following the insult, that is, striatal medium spiny neurons (Arvidsson and others 2002; Parent and others 2002) . These findings have raised the possibility that functional improvement after stroke may be induced through neuronal replacement from endogenous neural stem cells (NSCs) in the adult brain.
Here we describe some of our most recent, partly unpublished data with focus on 3 major scientific issues related to the regulation of neurogenesis after stroke: First, what is the duration of striatal neurogenesis after the ischemic insult? The neurogenic response has so far been thought to be acute and transient, lasting only for a couple of weeks and giving rise to very few new neurons. Second, can new neurons be formed from endogenous NSCs also in the aged brain? If striatal neurogenesis is maintained, it will raise the clinical interest in this mechanism because stroke mainly affects older people. Third, which are the molecular mechanisms regulating the directed migration of the new neurons to the damaged area and underlying the major loss of the new neuroblasts soon after they have been formed? Identification of these mechanisms could lead to new strategies to more efficiently attract the new neurons to the site of injury as well as increase their long-term survival.
Materials and Methods
In all studies described here, we used a well-characterized rat model of stroke induced by MCAO. With respect to both pathology and symptomatology, this model closely resembles the most common type of stroke in adult humans. Briefly, under halothane anesthesia, the middle cerebral artery of artificially ventilated rats was occluded with a nylon monofilament inserted through the common carotid artery (Koizumi and others 1986; Zhao and others 1994) . After 30 min or 2 h, the filament was withdrawn. The 30-min insult causes neuronal death restricted to the striatum, whereas 2 h MCAO leads to damage also to the overlying parietal cortex. For sham surgery, the filament is advanced only a few millimeters inside the internal carotid artery. Body temperature, arterial blood pressure, pO 2 , pCO 2 , and pH were monitored during surgery and kept within a predetermined physiological range.
For labeling of new cells, the mitotic marker 5-bromo-29-deoxyuridine (BrdU) (50 mg/kg intraperitoneal) was given either 3 times with 2-h interval and animals were killed 2 h thereafter (for assessing proliferation) or twice daily during 2 weeks and rats were then sacrificed up to 1 year later (for determining survival and differentiation). To determine the identity of the new cells, double-label immunocytochemistry with antibodies against BrdU and different phenotypical markers was performed and double staining was confirmed by confocal microscopy. Numbers of doublecortin+ (Dcx+) and Dcx+/BrdU+ cells were counted in the striatum at 340 magnification using an epifluorescence microscope with a 0.25-mm quadratic grid, the most medial column lining the SVZ. Four sections, evenly distributed throughout the striatum, were sampled from each animal.
Results

Stroke Leads to Long-Lasting Morphological and Functional Changes in the SVZ
Previous studies have demonstrated that maximum cell proliferation in the ipsilateral SVZ occurs at 1--2 weeks after MCAO (Arvidsson and others 2002; Zhang R, Zhang Z, Wang, and others 2004; Zhang R, Zhang Z, Zhang C, and others 2004) . We have now found (Thored and others 2005) increased number and size of neurospheres isolated from ipsilateral SVZ at 6 weeks post-MCAO and expansion of the size of the ipsilateral SVZ at both 2 and 6 weeks. When we injected the mitosis marker BrdU just before sacrifice at 4 days but not at 6 weeks after MCAO, BrdU labeling was increased in the ipsilateral SVZ. This observation argues against a long-term increase of the pool of rapidly dividing progenitors after stroke. Taken together, our findings provide evidence that stroke leads to long-term alterations in the stem cell niche in the SVZ.
Stroke Leads to Persistent Production of New Striatal Neurons
In order to determine the duration of the neurogenic response after stroke, we studied the occurrence of neuroblasts expressing Dcx in the striatum of adult rats at various time points after 2 h of MCAO. Dcx is a reliable marker of neurogenesis, which is transiently expressed (during about 2--3 weeks) in newly formed neuroblasts in both the intact and injured brain (Brown and others 2003; Couillard-Despres and others 2005) . Contralateral to the ischemic lesion, and in sham-operated animals, Dcx immunoreactivity was confined to the SVZ and a few striatal cells. In contrast, in the damaged striatum, the number of Dcx+ cells was elevated already at 1 week and was stable thereafter up to 16 weeks following the insult. At all time points, the Dcx+ cells migrated from the SVZ laterally and ventrally into the damaged area (Fig. 1) .
Following a milder stroke, 30 min of MCAO, which gave rise to a lesion restricted to the striatum, the neurogenic response was less pronounced. The number of Dcx+ cells correlated significantly with the volume of the striatal injury. Thus, the size of the ischemic lesion determines the degree of activation of the molecular and cellular mechanisms that promote recruitment of new striatal neurons after stroke.
We confirmed that neurogenesis occurs both early and late after stroke and that neuroblasts formed also months after the insult differentiate into mature neurons using BrdU injections (Fig. 2) . When BrdU was given during the first 2 weeks post-MCAO and animals were killed directly thereafter, many Dcx+ cells were also BrdU+ (45%). Similarly, when BrdU was injected during weeks 7 and 8 after MCAO, most of the Dcx+ neuroblasts (71%) were colabeled with BrdU. Four weeks after BrdU injections, these cells had lost their Dcx expression and differentiated into BrdU+ cells coexpressing the mature neuronal marker NeuN (Fig. 3) .
We have recently extended our findings on the duration of the neurogenic response after stroke by giving BrdU injections during 2 weeks in 5 rats subjected to 2 h MCAO 1 year earlier (Fig. 4 ). Animals were perfused 4 weeks after the last BrdU injection. All rats showed Dcx+ cells and fibers in the striatum ipsilateral to the ischemic damage, whereas no Dcx+ staining was found in the contralateral striatum. The number of Dcx+ cells corresponded to about one-fourth of that observed during the first 4 months (106 ± 13 and 428 ± 40 cells). New cells with a mature neuronal phenotype (NeuN+/BrdU+) were also found in the ischemic striatum in all animals. Interestingly, the ratio between NeuN+/BrdU+ cells and Dcx+ cells at 1 year was similar to that at 6 weeks (10% and 20%, respectively). Taken together, our findings indicate that striatal neurogenesis after Figure 1 . Distribution of new Dcx+ cells at 2, 6, and 16 weeks after stroke, from SVZ toward damaged striatum, and involvement of SDF-1a/CXCR4 signaling in the neuroblast migration. Note that there is no difference in the percentage of Dcx+ cells (of total number of Dcx+ cells) at different distances from SVZ at the 3 time points. Also note that after intraventricular infusion of the CXCR4 blocker AMD 3100 during weeks 5 and 6 after stroke, significantly more cells stay closer to SVZ and fewer cells migrate toward the damaged striatum. Means ± standard error of mean. *P < 0.05 compared with vehicle, unpaired t-test. . Schematic representation of stroke-induced striatal neurogenesis at early (A) and late (B) time points after 2 h MCAO. Production of Dcx+ striatal neuroblasts in the SVZ is maintained at the same level from 1 up to 16 weeks after stroke. Daily BrdU injections performed either early (weeks 1 and 2, A) or late (weeks 6 and 7, B) after 2 h MCAO lead to similar events: the number of Dcx+/BrdU+ newly formed neuroblasts, which is increased, is then gradually decreased with parallel increase of the number of NeuN+/BrdU+ new striatal mature neurons.
stroke continues at least for 1 year and that, despite a decline in the formation of new neuroblasts at this late time point, the yield of differentiated neurons seems to be rather unchanged.
Directed Migration of New Neurons to Damaged Area after Stroke Is Regulated by Stromal Cell--Derived Factor-1a
The chemokine stromal cell--derived factor-1a (SDF-1a) and its receptor C-X-C chemokine receptor 4 (CXCR4) have been reported to mediate homing of transplanted bone marrow--derived cells to sites of brain injury (Hill and others 2004; Ji and others 2004) and migration of grafted NSCs to the infarcted area after stroke (Imitola and others 2004) . During brain development, SDF-1a/CXCR4 signaling plays an important role for migration of neural progenitors (Lazarini and others 2003) . SDF-1a triggers in vitro migration of cells dissociated from adult mouse SVZ neurospheres (Tran and others 2004) , and CXCR4 is expressed by mouse SVZ progenitors (Tran and others 2004) . Finally, SDF-1 immunostaining is increased in the injured mouse striatum at least up to 4 weeks after stroke (Hill and others 2004) . We have now (Thored and others 2005) obtained several lines of evidence that SDF-1a/CXCR4 signaling is involved in the persistent migration of new striatal neuroblasts from SVZ to the damaged area after stroke in the adult brain. First, we found that SDF-1 expression was upregulated in the ischemic rat striatum, mainly in reactive astrocytes, at both early and late time points after stroke, that is, up to 16 weeks after 2 h MCAO. Second, we observed in vitro that SVZ neurosphere cells expressed the CXCR4 and migrated toward a gradient of SDF-1a. This migration was completely suppressed by the specific CXCR4 blocker AMD 3100. Finally, we infused AMD 3100 or vehicle intraventricularly in rats subjected to 2 h MCAO during weeks 5 and 6 after the insult (Fig. 1) . The AMD 3100 infusion caused a significant suppression of the migration of the newly formed neurons in the striatal parenchyma. In accordance with these findings, Robin and others (2005) reported from a parallel study that cultured SVZ progenitors exhibited increased migration when overlaid on stroke brain slices as compared with normal brain slices. Blocking SDF-1a by a neutralizing antibody against CXCR4 attenuated the stroke-enhanced migration. However, in our own experiments (Thored and others 2005) , AMD 3100 only partially suppressed the migration of the new striatal neurons in vivo, which may be due to incomplete blockade of the CXCR4, but probably indicates that other cellular and molecular mechanisms are also involved in directing the new neurons to the damaged area.
Many New Neurons Die within Weeks After Stroke Due to a Caspase-Mediated Apoptotic Mechanism
Only a portion of the stroke-generated striatal neuroblasts forms mature neurons. We have not obtained any evidence that the new neuroblasts remain in an undifferentiated state, which indicates that many of them die. The involvement of caspasemediated apoptotic death in the loss of these neurons is suggested by 2 main findings: First, that scattered Dcx+ cells in the ipsilateral striatum coexpressed active caspase-cleaved poly(adenosine diphosphate-ribose) polymerase (PARP) at both 2 and 8 weeks after MCAO (Thored and others 2005) . The PARP protein is a substrate of active caspases that upon cleavage by caspases becomes inactivated as apoptotic cell death is initiated (Herceg and Wang 2001) . Second, infusion of a caspase inhibitor cocktail or vehicle intraventricularly during the first 2 weeks after 2 h MCAO lead to markedly higher number of Dcx+ cells in the damaged striatum (Thored and others 2005) .
It is conceivable that inflammatory changes accompanying the ischemic damage contribute to the poor survival of the new striatal neurons. Inflammation suppresses neurogenesis in the dentate gyrus (Ekdahl and others 2003; Monje and others 2003) by compromising the survival of the new neurons. Also, the new striatal neurons will most likely die if they do not establish synaptic connections and receive appropriate trophic signals. Interestingly, we have found that a population of new neurons survived for 4 months after stroke, which suggests that integration and trophic support can be achieved to some extent in the stroke-damaged striatum (Thored and others 2005) .
Stroke-Induced Neurogenesis Is Maintained in the Aged Brain
We have explored whether stroke triggers neurogenesis in the aged brain also and compared young adult (3 months) and old (15 months) rats (Darsalia and others 2005) . There was a dramatic reduction of cell proliferation in the SVZ under basal conditions. At 7 weeks after 1 h MCAO, the number of new Dcx+ neuroblasts and mature NeuN+/BrdU+ neurons was higher in the ipsilateral as compared with contralateral striatum in both age groups. Interestingly, there were no significant differences in the numbers of new neuroblasts or mature neurons in the ischemic striatum between young and old animals. Thus, despite the low basal cell proliferation in the SVZ, this potential mechanism of self-repair operates also after stroke in the aged brain.
Discussion
The data described here demonstrate that a stroke, induced by MCAO in adult rats, leads to long-term alterations in the structure and function of the SVZ ipsilateral to the ischemic damage. At least up to 1 year after the insult, the SVZ continues to produce new neuroblasts, which migrate into the striatum and then adopt a mature neuronal phenotype. Thus, NSCs in the SVZ are a constant source of a cellular raw material, which could be used for self-repair in the brain during the recovery phase after stroke. In the following, we will discuss some of the most important issues to address in order to further explore the restorative potential of stroke-induced neurogenesis.
Can the New Stroke -Generated Neurons Become Morphologically and Functionally Integrated into the Brain? Striatal neurons that are generated in the intact brain by overexpressing brain derived neuotrophic factor and noggin in the ventricular wall can project to their normal target area, that is, the globus pallidus (Chmielnicki and others 2004) . However, following a stroke, target neurons may also have been damaged that could interfere with the regenerative process. Whether the stroke-generated striatal neurons receive afferents and form efferent connections with mature neurons that survived the insult is currently unknown.
Cells generated both in the hippocampal subgranular zone and in the SVZ of the intact brain exhibit the electrophysiological characteristics of functional neurons (van Praag and others 2002; Carleton and others 2003) . So far, patch-clamp recordings have not been possible from the stroke-generated striatal neurons because of technical problems with very ineffective transduction using available green fluorescent protein (GFP)-labeled viral vectors. Thus, it is not known whether the new neurons develop the functional properties of striatal neurons and if they become integrated into existing synaptic and neural circuitries. Labeling of NSCs in the SVZ and their progeny using a novel lentiviral-GFP vector (Consiglio and others 2004) may provide the solution to this problem.
Which Neuronal Phenotypes Can Be Generated from NSCs in the SVZ?
The most well-established new cell formed from NSCs in the SVZ and migrating into the striatum after stroke expresses markers characteristic of medium spiny neurons, that is, the type of neuron mainly affected by the lesion. Virtually, all newly generated neuroblasts express Pbx and Meis2 (Arvidsson and others 2002) , which are transcription factors observed in striatal medium spiny neurons during embryonic development. After maturation, about 50% of the new neurons express the specific marker for medium spiny neurons dopamine-and cyclic AMP-regulated phosphoprotein-32 (DARPP-32). But stroke also causes degeneration of striatal interneurons. Teramoto and others (2003) have reported generation of one type of striatal interneuron, parvalbumin-expressing neurons, in the striatum of epidermal growth factor--treated mice subjected to stroke. So far, the formation of cells expressing interneuron markers has not been shown after stroke in rats. However, using a different model of striatal injury, that is, intrastriatal injection of the excitotoxin quinolinic acid, we have demonstrated new neurons in the striatum expressing not only DARPP-32 but also markers of 2 types of striatal interneurons, parvalbumin and neuropeptide Y (Collin and others 2005) . Our data indicate that the SVZ can produce both striatal projection neurons and interneurons in response to damage. These neuron types, which are damaged both after stroke and after quinolinic acid infusion, have different origins during embryonic development, that is, lateral and medial ganglionic eminence, respectively (Marin and others 2000) . Whether the different striatal neuronal phenotypes generated in the adult brain arise from the same precursor population in the SVZ or if the projection neurons and interneurons maintain separate origins within the SVZ is currently unknown.
A crucial question is whether new neurons formed in the SVZ after stroke can migrate also to the damaged cerebral cortex. So far, this has not been convincingly demonstrated, and it is also unclear whether neurogenesis can be triggered from local NSCs in the cortical parenchyma. Interestingly, there is experimental evidence that under certain circumstances, neurogenesis can be induced in the adult cerebral cortex by cortical injury. Targeted apoptotic degeneration of cortical neurons in mice, leaving the tissue architecture intact, has been reported to lead to the formation of new cortical neurons extending axons to the thalamus (Magavi and others 2000) and spinal cord (Chen and others 2004) . In contrast, only one report (Jin and others 2003) has described migration of Dcx+ neuroblasts into the penumbra of the ischemic cortex after stroke. Similarly, only one group has observed the presence of BrdU+ cells colabeled with the marker of mature neurons NeuN in the stroke-damaged cortex ( Jiang and others 2001) . Other studies from several laboratories have failed to detect migration of the newly formed Dcx+ neuroblasts from the SVZ to the cerebral cortex or any significant numbers of mature NeuN+/BrdU+ cortical neurons after stroke (Zhang and others 2001; Arvidsson and others 2002; Parent and others 2002) . Taken together, these data indicate that in the ischemically damaged cortex, the cues necessary to trigger substantial migration of neuroblasts from the SVZ or neurogenesis from local parenchymal NSCs are lacking.
Which Are the Functional Consequences of Stroke-Induced Neurogenesis? The long-lasting neurogenesis from endogenous NSCs after stroke occurs concomitantly with the spontaneous recovery of motor function, which is observed both in experimental animals and in humans. Similarly, delivery of several growth factors and other compounds during the first weeks after the insult promotes both striatal neurogenesis and behavioral improvement. Although these observations suggest a functional role of stroke-induced neurogenesis, there is at present no direct evidence of a causal relationship between the formation of new neurons and the symptomatic relief. It is a major challenge for this research field to develop strategies to distinguish, in a conclusive way, the functional consequences of neurogenesis. This is required in order to efficiently optimize the improvement induced by neurogenesis. One possibility could be to deliver after the stroke a mitosis inhibitor such as cytosine-b-Darabionfuranoside (Ara-C), which can dramatically suppress cell proliferation in SVZ. The problem with this approach is that Ara-C will block proliferation also of other cell types in different parts of the brain. It will, therefore, be difficult to attribute observed behavioral changes after Ara-C to the lack of neurogenesis. A more attractive solution could be to generate conditional transgenic mice in which the new neurons found after stroke can be selectively ablated.
In conclusion, much work remains in exploring the potential of the adult brain's self-repair mechanisms. Hypothetically, this basic research may lead to clinical applications in the future. However, before any studies in patients are even considered, we must know much more about how to control proliferation of NSCs in the SVZ, migration of the new neuroblasts to the damaged area, and their differentiation into specific phenotypes. We must also be able to induce functional integration of the new neurons into existing synaptic and neural circuits and to stimulate the neurogenesis for optimum functional recovery in animal models.
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